Breast Cancer News and Research

Latest Breast Cancer News and Research

BHGI sponsors global summit on international breast health

For women with breast cancer in low- and middle-resource countries and other medically underserved areas around the world, the need for supportive care and the consideration of quality-of-life issues are often overlooked.

2 Oct 2012

OS data from ImmunoGen's trastuzumab emtansine Phase III trial on breast cancer

ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.

2 Oct 2012

GnRH agonist may protect breast cancer patient fertility

Treatment with a gonadotropin-releasing hormone agonist may reduce the risk for chemotherapy-induced amenorrhea, research shows.

1 Oct 2012

ProStrakan acquires US commercial rights to Fareston for treatment of metastatic breast cancer

ProStrakan Group plc announces today that it has acquired exclusive US commercial rights to Fareston (toremifene citrate) for the treatment of metastatic breast cancer in postmenopausal women.

1 Oct 2012

Study opens new door to more personalized treatment of advanced breast cancer

For the first time, researchers have conducted a large trial in which they tested the entire genome of individual breast cancers to help personalize treatment. They released their findings at the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna.

1 Oct 2012

New insights on global fight to prevent cancers

New insights on the global fight to prevent cancers were presented during the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna. The studies highlight the challenges of overcoming misunderstandings about how important lifestyle factors are in reducing cancer risk.

1 Oct 2012

HR status defines two different subsets of HER2 positive cancers

Human epidermal growth factor (HER2) positive breast cancers are often treated with the same therapy regardless of hormone receptor status. New research published in BioMed Central's open access journal Breast Cancer Research shows that women whose HER2 positive cancer was also hormone (estrogen and progesterone) receptor (HR) negative had an increased risk of early death, and that their cancer was less likely to recur in bone than those whose cancer retained hormone sensitivity.

1 Oct 2012

Lilly announces new data from two Phase II ramucirumab trials on NSCLC

Eli Lilly and Company today announced new data from two Phase II ramucirumab (IMC-1121B) trials in patients with non-small cell lung cancer (NSCLC).

1 Oct 2012

New studies reveal real economic and human costs of caring for cancer patients in Europe

New studies that reveal for the first time the real economic and human costs of caring for cancer patients in Europe will be presented during the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna.

29 Sep 2012

Synta announces results from ganetespib Phase 2b trial on NSCLC

Synta Pharmaceuticals Corp. today announced results from an interim analysis of the Phase 2b portion of the GALAXY trial, a global, randomized, multi-center Phase 2b/3 study designed to evaluate the efficacy and safety of the Company's lead Hsp90 inhibitor, ganetespib, as second-line treatment for advanced non-small cell lung cancer (NSCLC).

29 Sep 2012

PLOS ONE journal releases report on validation of Falcon Genomics' Cancer BioChip System

The online journal PLOS ONE released a scientific report on the validation of Falcon Genomics' Cancer BioChip System (CBCS) as a tool for identifying inhibitors of breast cancer.

29 Sep 2012

State highlights: Free Calif. health care clinic a big draw; New Calif. law could mean mammogram alternatives

Many of the 4,800 people seeking care at the annual massive free clinic this weekend will become eligible for health insurance in 2014 when the national law takes effect. Organizers said raising awareness about the health care changes is crucial.

29 Sep 2012

AVEO submits tivozanib NDA with FDA for treatment of advanced renal cell carcinoma

AVEO Oncology and Astellas Pharma Inc. today announced that AVEO has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for tivozanib in patients with advanced renal cell carcinoma (RCC).

29 Sep 2012

Provectus amends and expands protocol for PV-10 Phase 1 hepatocellular carcinoma study

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced that it has amended and expanded the scope of the protocol PV-10-LC-01, "A Phase 1 Study to Assess the Safety, Tolerability and Pharmacokinetics of PV-10 Chemoablation of Cancer Metastatic to the Liver or Hepatocellular Carcinoma not Amenable to Resection or Transplant."

28 Sep 2012

New understanding about function of MYC proteins

Scientists may have discovered why a protein called MYC can provoke a variety of cancers. Like many proteins associated with cancer, MYC helps regulate cell growth. A study carried out by researchers at the National Institutes of Health and colleagues found that, unlike many other cell growth regulators, MYC does not turn genes on or off, but instead boosts the expression of genes that are already turned on.

28 Sep 2012

Cancer Institute of New Jersey to benefit from Panera Bread's Pink Ribbon Bagel

For more than a decade, "thinking pink" has been a tradition for Panera Bread bakery-cafés in their effort to highlight breast cancer awareness in their local communities during the month of October. That campaign, which marks National Breast Cancer Awareness Month, continues this year, with the offering of the Pink Ribbon Bagel.

27 Sep 2012

Viewpoints: 'Redistribution' debate; Reducing delayed, missed and incorrect diagnoses

The Affordable Care Act, which levies new taxes on the wealthy to expand access to health care for the near poor, seems on track to become the biggest increase in government redistribution since the Johnson administration.

27 Sep 2012

KSU creates simple blood test that can accurately detect lung and breast cancer’s early stages

Researchers at Kansas State University have developed a simple blood test that can accurately detect the beginning stages of cancer.

27 Sep 2012

New optical imaging technology could aid in breast cancer diagnosis and treatment

New optical imaging technology developed at Tufts University School of Engineering could give doctors new ways to both identify breast cancer and monitor individual patients' response to initial treatment of the disease.

27 Sep 2012

CTCA at Midwestern named Certified Quality Breast Center of Excellence

Cancer Treatment Centers of America (CTCA) at Midwestern Regional Medical Center (Midwestern) has been recognized by the National Quality Measures for Breast Centers Program (NQMBC) as being among the top centers in the country for providing quality breast cancer care.

27 Sep 2012

Breast Cancer News and Research

Latest Breast Cancer News and Research

BHGI sponsors global summit on international breast health

OS data from ImmunoGen's trastuzumab emtansine Phase III trial on breast cancer

GnRH agonist may protect breast cancer patient fertility

ProStrakan acquires US commercial rights to Fareston for treatment of metastatic breast cancer

Study opens new door to more personalized treatment of advanced breast cancer

New insights on global fight to prevent cancers

HR status defines two different subsets of HER2 positive cancers

Lilly announces new data from two Phase II ramucirumab trials on NSCLC

New studies reveal real economic and human costs of caring for cancer patients in Europe

Synta announces results from ganetespib Phase 2b trial on NSCLC

PLOS ONE journal releases report on validation of Falcon Genomics' Cancer BioChip System

State highlights: Free Calif. health care clinic a big draw; New Calif. law could mean mammogram alternatives

AVEO submits tivozanib NDA with FDA for treatment of advanced renal cell carcinoma

Provectus amends and expands protocol for PV-10 Phase 1 hepatocellular carcinoma study

New understanding about function of MYC proteins

Cancer Institute of New Jersey to benefit from Panera Bread's Pink Ribbon Bagel

Viewpoints: 'Redistribution' debate; Reducing delayed, missed and incorrect diagnoses

KSU creates simple blood test that can accurately detect lung and breast cancer’s early stages

New optical imaging technology could aid in breast cancer diagnosis and treatment

CTCA at Midwestern named Certified Quality Breast Center of Excellence

How does norepinephrine influence anxiety-related behaviours?

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Breast Cancer News and Research

Latest Breast Cancer News and Research

How does norepinephrine influence anxiety-related behaviours?

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Newsletters you may be interested in